Article info
PDFPostScript
PostScript
Are the 5-hydroxymethylcytosine-based wd-scores really superior over α-fetoprotein for the early diagnosis of hepatocellular carcinoma?
- Correspondence to Dr Yongpeng Chen, Department of Infectious Disease, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; cyp{at}smu.edu.cn
Citation
Are the 5-hydroxymethylcytosine-based wd-scores really superior over α-fetoprotein for the early diagnosis of hepatocellular carcinoma?
Publication history
- Received September 16, 2019
- Revised October 6, 2019
- Accepted October 15, 2019
- First published October 25, 2019.
Online issue publication
September 07, 2020
Article Versions
- Previous version (25 October 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.